Verified

Boosting biorefinery competitiveness through biotech

European Commission

Expected Outcome:

Successful proposals will contribute to the implementation of the EU initiative on Biotechnology and Biomanufacturing, the EU Life Sciences Strategy, the updated EU Bioeconomy Strategy, the EU Biotechnology Act, the Clean Industrial Deal, the European Chemical Industry Action Plan and the upcoming EU Circular Economy Act.

Projects results are expected to contribute to the following expected outcomes:

Full industrial scale biorefinery and related value chain(s) for the sustainable production of bio-based products using biotech as a key enabling technology.
Availability of bio-based products meeting market and technical performance requirements as relevant for their respective application areas.
Improvement of sustainability, circularity and resource efficiency compared to relevant benchmark(s).
Contribution to increasing the EU’s strategic autonomy, resilience and competitiveness.

Scope:

Biorefineries integrating biotechnologies, underpinned by sustainably sourced bio-based feedstock, have a huge potential to transform the EU manufacturing landscape, spurring socio-economic growth, fostering job creation and contributing to defossilisation of the EU economy.

Europe is strong in life sciences including industrial biotechnology. However, research results often struggle to be deployed to the market; in most cases, scale-up needs de-risking and requires overcoming challenges in large-scale process and reactor design, cell productivity, efficient use of feedstock, operative condition stability, reactor sterility and efficient integration of downstream operations among others.

Proposals under this topic should:

Demonstrate (at TRL 8) a sustainable and robust biomanufacturing route to obtain bio-based product(s). The proposal should focus on processes in which biotechnology is the key enabling technology; the integration of (upstream and/or downstream) supporting unit operations based on technologies other than biotechnology is in scope. Products in scope include chemicals, intermediates, polymers, ingredients and enzymes. Food and feed ingredients as main application are out of scope. Optimisation of selected cells, enzymes and/or microorganisms is also in scope provided that the starting TRL is at least 6.
Demonstrate (at TRL 8) the further conversion or use of the obtained biorefinery product(s) into at least one end-product driving the business case; validate it (TRL 6 and above) in relevant market applications. Additional end-product(s) with high prospective market potential can be targeted, reaching at least TRL 6.

In addition to the specific requirements applicable for the type of action, as described in section 2.2.3.1 of the CBE JU Annual Work Programme 2026[1], proposals under this topic should:

As part of the multi-actor approach (MAA), ensure adequate involvement of all key actors in the value chains relevant for this topic and across the sustainable circular bio-based system, including feedstock providers, policymakers and end users.
Address compliance with EU regulatory frameworks as relevant for targeted products and applications, identify potential gaps and provide recommendations to overcome them. Perform a risk assessment on impacts, potentially deriving from the use of biotechnology, on human and ecosystem safety and identify adequate mitigation measures. Assess the adequacy of policy and regulatory means to manage these risks and provide recommendations to overcome potential identified bottlenecks.
Include a task to apply the SSbD framework, developed by the European Commission, for the assessment of the production process of targeted biorefinery product(s) as well as the chosen derived end product(s). For more information on the SSbD framework and criteria, refer to Safe and sustainable by design.
Seek complementarities and avoid overlaps with past and ongoing R&I projects addressing similar challenges, including those funded by BBI JU/CBE JU and under Horizon 2020/Horizon Europe (under Cluster 6 and other Clusters of Horizon Europe).

AI Based Application Success Predictor

All Horizon Europe proposals are scored on three decisive pillars:

✔️ Excellence

Clear, innovative idea beyond state-of-the-art
Strong methodology and scientific credibility
Well-defined, measurable objectives

✔️ Impact (most decisive in practice)

Demonstrated societal, economic, or environmental impact
Strong dissemination & exploitation plan
Alignment with EU priorities (Green Deal, digital, SDGs)

✔️ Quality & Efficiency of Implementation

Realistic work plan, timeline, and deliverables
Clear governance and task distribution
Feasible and justified budget

👉 Proposals must meet minimum thresholds (≈10/15 total) and ≥3 per criterion to be fundable

🧠 2. Consortium Strength (Top Empirical Predictor)

From large-scale studies of EU Framework grants:

Key factors:

Prior EU funding experience (very strong predictor)
High scientific reputation / excellence of partners
Strong existing collaborations (network familiarity)
High “network visibility” in EU research ecosystem

Structural advantages:

Balanced consortium (academia + industry + SMEs)
Inclusion of well-established Western EU institutions
Application-oriented collaborations perform better

👉 This is one of the most consistently proven predictors across studies

🌍 3. Strategic Consortium Composition

Successful proposals often show:

Multidisciplinary & cross-sector teams
Inclusion of:
- Universities
- Industry/SMEs
- Public or non-profit organizations
Alignment of partner roles with project objectives

👉 “Triangular collaboration” (academia + industry + research orgs) is common in funded projects

📊 4. Strong Alignment with Call Topic

Precise match with call scope and expected outcomes
Explicit referencing of:
- Work Programme priorities
- EU missions / policy goals
Avoid “generic” proposals

👉 Misalignment is a major reason for rejection (even for strong science)

📑 5. Proposal Quality & Compliance

Critical but often underestimated predictors:

Full compliance with:
- Formatting rules
- Page limits
- Mandatory annexes
Clear, readable, structured writing
Inclusion of ethics, gender, and data management plans

👉 Administrative errors can lead to automatic rejection

💰 6. Budget Credibility

Budget must be:
- Realistic
- Justified per work package
- Linked to outputs

👉 Weak or inflated budgets reduce evaluation scores

⏳ 7. Preparation Time & Proposal Development

Successful consortia typically:
- Start 6–8 months in advance
- Iterate drafts and internal reviews
Proposal preparation often requires 2–3 person-months effort

📈 8. Experience with Evaluation Process

Understanding scoring system and evaluator mindset is crucial
Key predictors:
- Prior submissions (even unsuccessful ones)
- Use of experienced coordinators or consultants

👉 Studies show success depends on both:

Excellent idea
Understanding evaluation system

📉 9. Success Rate Context (Competitiveness)

Average success rate ≈ 16% in Horizon Europe

👉 Meaning: even strong proposals fail → optimization of all predictors is essential

🧩 Summary: Most Important Predictors (Ranked)

Highest impact factors:

Strong consortium (experience + reputation)
Clear impact (policy + societal relevance)
Excellence of idea

Moderate but critical:
4. Implementation quality
5. Call alignment
6. Budget credibility

Supporting factors:
7. Proposal writing quality & compliance
8. Early preparation
9. Familiarity with EU evaluation process

💡 Practical Insight

The biggest shift from Horizon 2020 → Horizon Europe is:

👉 Impact is now as important (or more) than scientific excellence

Specialties

Others

Eligibility Requirements

General conditions

1. Admissibility conditions: Proposal page limit and layout

described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.

Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.

2. Eligible countries

described in Annex B of the Work Programme General Annexes.

A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.

3. Other Eligibility Conditions

described in Annex B of the Work Programme General Annexes.

Sponsor Details

Sponsor Institute/Organizations: European Commission

Sponsor Type: Government/Federal

Address: Berlaymont Building, Rue de la Loi 200, 1040 Brussels

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity